DOI:

Editorial

Patrick W. Serruys, Editor-in-chief

Our EuroIntervention adventure is now entering its second year and we take great pride in welcoming you to an issue which we hope you will find as exciting and interesting as we do. Like everything in our relatively young specialty, this is a fruit of the labour and vision of many. Collaboration and vision is what has made what we are doing today possible and that is why we continue to remember with great respect the early years of our work, with first hand accounts by Drs. Roubin and Sousa of their “First Twenty years of Stenting”.

But as you know, we do not sit on our laurels. Progress, and the problems we need to address move us on and we invite you to examine the challenges of unified European speciality training by reading the proposals of Working Group 10 of the European Society of Cardiology, participants in – and regular contributors to – our journal.

One of our key articles is from Marie-Claude Morice introducing us to the latest from JUPITER II. This is the randomized trial comparing the performance of tacrolimus-eluting stents (TES) with equivalent carbon-coated stents and involves over 300 patients with de novo coronary stenoses. We have another article discussing the ERACI III study, which extends the results of the excellent earlier ERACI trials to the widespread use of DES in today’s clinical practice, comparing a non-randomized cohort to a previously published patient population.

EuroIntervention then turns toward the ongoing concern with diabetes. In an article by Keith Dawkins, we have a reflection on the benefit of TAXUS stents over bare metal stents in this high-risk group for restenosis. Though the paper is essentially a meta-analysis, it is not without its hands-on side, offering practical information on how to optimize therapy in diabetic patients requiring pharmacotherapy. Another article by Carlos Macaya analyses existing studies, this time focusing on the subset analysis of diabetic patients enrolled in ARTS-I and II. Adverse outcomes of the diabetic patients vs non-diabetic patients are shown, demonstrating that overall MACCE rates in diabetic patients are significantly higher. We will continue addressing these problems in upcoming issues of our journal.

There are articles and technical reports on the controversial area of assist devices in high-risk PCI. Special case reports on percutaneous ventricular restoration, with an accompanying technical report of a world premiere device… and additional information – including videos – of these devices and much more on our increasingly popular website, do not forget to join us there.

And of course this issue is coming to you at the same time as the EuroPCR, which needs no introduction. As Jean Marco says in his editorial, “innovation is the path” we have chosen to follow. And it is an innovation based on our work together, on our ability to communicate, on our commitment to clarity and ethics and we are happy that EuroIntervention is now an essential part of this endeavour.

Volume 2 Number 1
May 20, 2006
Volume 2 Number 1
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00005 Mar 17, 2025
Unveiling the coronary acetylcholine test: can it help us predict future cardiovascular events?
Escaned J and Paolucci L
free

Flashlight

10.4244/EIJ-D-24-00248 Mar 17, 2025
Endovascular treatment of tandem lesions in a novel cadaveric stroke model
Grunwald I et al

Letter to the editor

10.4244/EIJ-D-24-00974 Mar 17, 2025
LETTER: An update on changes to the design of the ODIN trial
Sandner S et al
free
Trending articles
57.8

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
39.45

Clinical research

10.4244/EIJ-D-23-00725 Nov 19, 2023
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
39.45

Original Research

10.4244/EIJ-D-23-00725 Mar 18, 2024
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
36

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
35.15

State-of-the-Art

10.4244/EIJ-D-23-00895 Apr 1, 2024
Percutaneous interventions for pulmonary embolism
Finocchiaro S et al
free
28.5

CLINICAL RESEARCH

10.4244/EIJV11I1A6 May 19, 2015
European expert consensus on rotational atherectomy
Barbato E et al
free
22.55

CLINICAL RESEARCH

10.4244/EIJV12I5A93 Aug 5, 2016
Longer pre-hospital delays and higher mortality in women with STEMI: the e-MUST Registry
Benamer H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved